Abstract:The aggregation of alpha-Synuclein (alpha-Syn) into amyloid fibrils is the hallmark of Parkinson's disease. Under stress or other pathological conditions, the accumulation of alpha-Syn oligomers is the main contributor to the cytotoxicity. A potential approach for treating Parkinson's disease involves preventing the accumulation of these alpha-Syn oligomers. In this study, we present a novel mechanism involving a conserved group of disorderly proteins known as small EDRK-rich factor (SERF), which promotes the aggregation of alpha-Syn through a cophase separation process. Using diverse methods like confocal microscopy, fluorescence recovery after photobleaching assays, solution-state NMR spectroscopy, and Western blot, we determined that the N-terminal domain of SERF1a plays a role in the interactions that occur during cophase separation. Within these droplets, alpha-Syn undergoes a gradual transformation from solid condensates to amyloid fibrils, while SERF1a is excluded from the condensates and dissolves into the solution. Notably, in vivo experiments show that SERF1a cophase separation with alpha-Syn significantly reduces the deposition of alpha-Syn oligomers and decreases its cellular toxicity under stress. These findings suggest that SERF1a accelerates the conversion of alpha-Syn from highly toxic oligomers to less toxic fibrils through cophase separation, thereby mitigating the biological damage of alpha-Syn aggregation.

VAMP2 regulates phase separation of α-synuclein

VAMP2 regulates phase separation of alpha-synuclein

VAMP2 chaperones α-synuclein in synaptic vesicle co-condensates

Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling

The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition

Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2

Membrane association of VAMP2 SNARE motif in cells and its regulation by different lipid phases of synaptic vesicle membrane

Synapsin 2a tetramerisation selectively controls the presynaptic nanoscale organisation of reserve synaptic vesicles

Single-vesicle Imaging Quantifies Calcium’s Regulation of Nanoscale Vesicle Clustering Mediated by Α-Synuclein

Different regions of synaptic vesicle membrane regulate VAMP2 conformation for the SNARE assembly

β-synuclein regulates the phase transitions and amyloid conversion of α-synuclein

-Synuclein phase separation and amyloid aggregation are modulated by C-terminal truncations

Α-Synuclein: A Multifunctional Player in Exocytosis, Endocytosis, and Vesicle Recycling

Aggregation and phase separation of α-synuclein in Parkinson's disease

Actin-nucleation promoting factor N-WASP influences alpha-synuclein condensates and pathology

Altered Conformation of Α-Synuclein Drives Dysfunction of Synaptic Vesicles in a Synaptosomal Model of Parkinson's Disease.

Synapsin E-domain is essential for α-synuclein function

Divergent effects of pathological α-synuclein truncations and mutations on phase separation

α-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword

The Disordered Protein SERF Promotes Α-Synuclein Aggregation Through Liquid-Liquid Phase Separation

N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine